Results 111 to 120 of about 3,560 (171)

The efficacy and safety of thrombopoietin receptor agonists in solid tumors with chemotherapy-induced thrombocytopenia: a systematic review and network meta-analysis of randomized controlled trials. [PDF]

Front Pharmacol
Lai Y, Pan Q, Wang S, Luo Q, Huang Z, Wei M, Jiang Z, Yi W.   +7 more
europepmc   +1 more source

Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multi-Refractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists. [PDF]

Mediterr J Hematol Infect Dis, 2023
Carpenedo M, Zappaterra A, Ferrari B, Cotilli G.   +3 more
europepmc   +1 more source

Impact of Primary Chronic Immune Thrombocytopenia and Thrombopoietin Receptor Agonists Treatment Instructions on Daily Living: Results of a Multinational Cross-Sectional Survey. [PDF]

Patient Prefer Adherence
Zwaginga JJ, Nagalla S, Linden M, Lindberg MH, Kruse C, Morgan M, Yssing C, Decise D, Putnik M, Rich C.   +9 more
europepmc   +1 more source

Effective treatment of refractory aplastic anemia with romiplostim after failure of multiple thrombopoietin receptor agonists: a single-center retrospective study. [PDF]

Ann Med
Lin X, Yang C, Liu Z, Zhuang J, Chen M, Han B.   +5 more
europepmc   +1 more source

Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature. [PDF]

Front Oncol, 2021
Capecchi M, Serpenti F, Giannotta J, Pettine L, Reda G, Martinelli I, Artoni A, Barcellini W, Fattizzo B.   +8 more
europepmc   +1 more source

Relationship between thromboembolic events and thrombopoietin receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System and the Japanese Adverse Drug Event Report. [PDF]

BMJ Open
Huang X, Liao X, Huang Y, Zhang C, Wang Z, Yu L.   +5 more
europepmc   +1 more source

Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists. [PDF]

Drugs, 2021
Gilreath J, Lo M, Bubalo J.
europepmc   +1 more source

Bridging the gaps between randomized controlled trials and real-world use of thrombopoietin receptor agonists for adult primary immune thrombocytopenia: a systematic review and meta-analysis. [PDF]

Front Med (Lausanne)
Luo L, Jin S, Song Z, Chong G, Ding H, Zeng S, Dai M, Wu M.   +7 more
europepmc   +1 more source